Androgen receptor association with mitotic chromatin - analysis with introduced deletions and disease-inflicting...

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Androgen receptor (AR) gene and protein anomalies link to various clinical conditions.
• AR translocates to the nucleus upon ligand binding, forming nuclear foci for gene transcription.
• Previous work proposed a 'biopit model' for AR's role in 'transcription memory' via mitotic chromatin association.

Purpose of the Study:

• To investigate the role of AR domains and the NLS in mitotic chromatin association.
• To determine the necessity of full-length AR for efficient chromatin binding.
• To explore the impact of AR-NLS mutants on localization, nuclear foci, and chromatin binding.

Main Methods:

• Cellular observations of AR localization and nuclear foci formation.
• Analysis of AR domain and full-length protein requirements for mitotic chromatin binding.
• Utilizing deletion and point mutations in the AR bipartite nuclear localization signal (NLS).
• Examining AR-NLS mutants associated with prostate cancer and androgen-insensitivity syndrome.

Main Results:

• All AR domains are obligatory for mitotic chromatin association; full-length AR is necessary for efficient binding.
• AR-NLS mutants showed impaired localization, nuclear foci formation, and abolished mitotic chromatin binding.
• Pathological AR-NLS mutants displayed differential mitotic chromatin behavior and impaired receptor functions.
• The AR-NLS region was identified as a 'mitotic chromatin binding-determining region'.

Conclusions:

• The AR-NLS region is crucial for AR's association with mitotic chromatin, beyond its role in nuclear import.
• AR-NLS mutations disrupt AR localization, nuclear foci formation, and chromatin binding, with implications for disease.
• The AR-NLS region has a novel regulatory role in AR's association with mitotic chromatin and 'transcription memory'.